Why Mouth-Dissolving Antipsychotic Tablets Are Gaining Ground in India's Neuro PCD Franchise Segment
Most content about neuropsychiatry franchises talks about market size and monopoly rights. Fewer talk about the one clinical problem that's quietly reshaping which formulations franchise partners should actually be stocking: medication adherence in psychiatric care, and why the mouth-dissolving (MD) tablet format has become a meaningful business consideration, not just a manufacturing...
0 Comments 0 Shares 60 Views 0 Reviews
Sponsored